Lorne Proteomics: Getting more out of proteomics
22 March, 2005 by Susan WilliamsonThe Lorne Proteomics Symposium is geared towards assessing practical solutions for the technology.
Lorne Protein: Workshopping protein folding
22 March, 2005 by Graeme O'NeillThis year's Lorne Protein conference was preceded by a one-day workshop-style event, the Biomolecular Dynamics and Interactions Symposium, at the new Bio21 Molecular Science and Biotechnology Institute in Melbourne's Parkville.
Lorne Protein: Mr Namba's marvellous molecular machine
22 March, 2005 by Graeme O'NeillGraeme O'Neill learns about the ingenious engineering behind the molecular motor of the bacterial flagellum.
Lorne Protein: Jack Martin's Cheshire cat
22 March, 2005 by Graeme O'NeillThe Leach lecturer at the 2005 Lorne Protein conference has a persistent streak, Graeme O'Neill discovers.
Lorne Protein: The protein pioneers
22 March, 2005 by Graeme O'NeillThe Lorne Conference on Protein Structure and Function is celebrating its 30th anniversary this year. Graeme O'Neill discovers why there's plenty to celebrate.
Interview: Heartfelt genetics
22 March, 2005 by Melissa TrudingerMelissa Trudinger meets Richard Harvey, the recipient of the 2005 Julian Wells Medal.
Lorne Genome: Gaps in the genome
22 March, 2005 by Melissa TrudingerMelissa Trudinger takes a candid look at the state of genomics research in Australia.
Lorne Genome: True blue genomics
22 March, 2005 by Melissa TrudingerAcross the Australian research landscape, small genome projects are pushing their heads above the ground.
Lorne Genome: O Canada! Can we copy your example?
22 March, 2005 by Melissa TrudingerCanada was one of the first countries to hop on the genomics bandwagon after the human genome project was completed. Since 2001, the Canadian federal government has invested C$386 million into Genome Canada, an independently operated organisation with the role of coordinating and funding genomics and proteomics research across Canada.
Proteome snags grant for TB test
17 March, 2005 by Graeme O'NeillSydney's Proteome Systems has won a US$2 million federal government R&D Start grant to advance development of its new rapid diagnostic for tuberculosis.
Nanyang invests $2.5m in Genetic Solutions
17 March, 2005 by Graeme O'NeillSydney venture capital company Nanyang Ventures has injected $2.5 million into Genetic Solutions to help accelerate the Brisbane genetic information-technology company's product development and international marketing initiatives.
Nucleonics responds to criticisms of new patents
14 March, 2005 by Graeme O'NeillRNA-interference therapeutics company Nucleonics has disputed claims by Queensland rival Benitec (ASX:BTL) that two new Australian patents on RNAi technology granted to the Medical College of Georgia Research Institute are "largely irrelevant" to companies involved in medical applications of RNAi.
Nucleonics granted two RNAi patents by IP Australia
10 March, 2005 by Graeme O'NeillRNA-interference therapeutics company Nucleonics has announced that IP Australia has granted the Medical College of Georgia Research Institute (MCGRI) two patents covering an RNAi gene-silencing technique. Nucleonics is a licensee to both patents.
Gene chip could save dairy industry big bucks
04 March, 2005 by Graeme O'NeillMastitis, or bacterial infections of the udder, is a AUD$140 million a year problem for Australia's dairy industry. It can cost farmers up to $150 an animal to treat, and affects both milk output and quality.
Sydney researchers identify bipolar gene
02 March, 2005 by Graeme O'NeillResearchers at Sydney's Garvan Institute have identified a gene coding for a cell-adhesion molecule in the brain as a strong risk factor for bipolar disorder, or manic depression.
